244 related articles for article (PubMed ID: 38255798)
21. Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas.
Chamberlain MC
Cancer; 2010 Sep; 116(17):3988-99. PubMed ID: 20564141
[TBL] [Abstract][Full Text] [Related]
22. Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis.
Di Carlo DT; Cagnazzo F; Benedetto N; Morganti R; Perrini P
Neurosurg Rev; 2019 Jun; 42(2):263-275. PubMed ID: 29138949
[TBL] [Abstract][Full Text] [Related]
23. Radiosensitization of high-grade gliomas through induced hyperthermia: Review of clinical experience and the potential role of MR-guided focused ultrasound.
Schneider CS; Woodworth GF; Vujaskovic Z; Mishra MV
Radiother Oncol; 2020 Jan; 142():43-51. PubMed ID: 31431370
[TBL] [Abstract][Full Text] [Related]
24. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
25. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
26. 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas.
Mahmoudi K; Garvey KL; Bouras A; Cramer G; Stepp H; Jesu Raj JG; Bozec D; Busch TM; Hadjipanayis CG
J Neurooncol; 2019 Feb; 141(3):595-607. PubMed ID: 30659522
[TBL] [Abstract][Full Text] [Related]
27. A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
Ciliberto D; Staropoli N; Caglioti F; Gualtieri S; Fiorillo L; Chiellino S; De Angelis AM; Mendicino F; Botta C; Caraglia M; Tassone P; Tagliaferri P
Cancer Biol Ther; 2015; 16(8):1148-59. PubMed ID: 26061272
[TBL] [Abstract][Full Text] [Related]
28. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
29. Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study.
Garibotto F; Madia F; Milanaccio C; Verrico A; Piccardo A; Tortora D; Piatelli G; Diana MC; Capra V; Garrè ML; Rossi A; Morana G
Front Oncol; 2020; 10():795. PubMed ID: 32582540
[No Abstract] [Full Text] [Related]
30. Intraoperative Magnetic Resonance Imaging for Low-Grade and High-Grade Gliomas: What Is the Evidence? A Meta-Analysis.
Lo YT; Lee H; Shui C; Lamba N; Korde R; Devi S; Chawla S; Nam Y; Patel R; Doucette J; Bunevicius A; Mekary RA
World Neurosurg; 2021 May; 149():232-243.e3. PubMed ID: 33540099
[TBL] [Abstract][Full Text] [Related]
31. Role of glioma stem cells in promoting tumor chemo- and radioresistance: A systematic review of potential targeted treatments.
Agosti E; Zeppieri M; Ghidoni M; Ius T; Tel A; Fontanella MM; Panciani PP
World J Stem Cells; 2024 May; 16(5):604-614. PubMed ID: 38817336
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic therapy for high-grade gliomas.
Chamberlain MC; Raizer J
CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):184-94. PubMed ID: 19601816
[TBL] [Abstract][Full Text] [Related]
33. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
34. Bevacizumab is an active agent for recurrent high-grade glioma, but do we need randomized controlled trials?
Morris PG
Anticancer Drugs; 2012 Jul; 23(6):579-83. PubMed ID: 22407251
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.
Amato A; Imbimbo BP; Falsini B
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5636-5653. PubMed ID: 37401302
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.
Guo C; Yang Q; Xu P; Deng M; Jiang T; Cai L; Li J; Sai K; Xi S; Ouyang H; Liu M; Li X; Li Z; Ni X; Cao X; Li C; Wu S; Du X; Su J; Xue X; Wang Y; Li G; Qin Z; Yang H; Zhou T; Liu J; Hu X; Wang J; Jiang X; Lin F; Zhang X; Ke C; Lv X; Lv Y; Hu W; Zeng J; Chen Z; Zhong S; Wang H; Chen Y; Zhang J; Li D; Mou Y; Chen Z
JAMA Netw Open; 2023 Jan; 6(1):e2253285. PubMed ID: 36705923
[TBL] [Abstract][Full Text] [Related]
37. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
Antonucci L; Canciani G; Mastronuzzi A; Carai A; Del Baldo G; Del Bufalo F
Front Immunol; 2022; 13():867154. PubMed ID: 35603195
[TBL] [Abstract][Full Text] [Related]
38. Reported outcomes of children with newly diagnosed high-grade gliomas treated with nimotuzumab and irinotecan.
Sirachainan N; Boongird A; Swangsilpa T; Klaisuban W; Lusawat A; Hongeng S
Childs Nerv Syst; 2017 Jun; 33(6):893-897. PubMed ID: 28439659
[TBL] [Abstract][Full Text] [Related]
39. Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis.
Upadhyay R; Khose S; Pokhylevych H; Paulino AC; McAleer MF; Ghia A; Li J; Yeboa DN; Loghin M; Harrison R; O'Brien B; Kamiya-Matsuoka C; De Groot J; Puduvalli VK; Tatsui C; Alvarez-Breckenridge C; Prabhu S; Rhines L; Zaky W; Lin F; Weinberg JS; Fuller G; Sandberg DI; Johnson JM; McGovern SL
Neurooncol Adv; 2022; 4(1):vdac129. PubMed ID: 36128585
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab for the treatment of high-grade glioma.
Khasraw M; Simeonovic M; Grommes C
Expert Opin Biol Ther; 2012 Aug; 12(8):1101-11. PubMed ID: 22663137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
